Theralink Technologies to Participate in the LD Micro Main Event Conference on October 25-27 – Yahoo Finance
Denver, Colorado–(Newsfile Corp. – October 11, 2022) – Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision medicine company with a novel phosphoprotein-based assay for breast cancer, today announced that Mick Ruxin, M.D., President & CEO of Theralink, will participate in the LD Micro Main Event XV on October 25-27, 2022.
The LD Micro Main Event XV
Date: October 25-27, 2022
Location: Luxe Sunset Boulevard Hotel Bel Air, California
Registration: Virtual or In-Person
Dr. Ruxin will be available for one-on-one investor meetings for the duration of the conference. To arrange a one-on-one meeting with the Theralink management team, please contact your LD Micro representative or KCSA Strategic Communications by emailing Theralink@KCSA.com.
About Theralink Technologies, Inc.
Theralink Technologies is a proteomics-based, precision medicine company with a CLIA-certified laboratory located in Golden, Colorado. Through its unique and patented phosphoprotein and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition to the Company’s first assay for advanced breast cancer, Theralink is actively working on a second assay that is planned to be pan-tumor for solid tumors across multiple tumor types such as ovarian, endometrial, pancreatic, liver, head and neck, gastrointestinal, lung, prostate, among others. Theralink provides precision oncology data through its powerful Theralink® Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. Theralink intends to help improve cancer outcomes for patients, help reveal therapeutic options for oncologists, and support biopharmaceutical drug development by using a beyond-genomics approach to molecular profiling that directly measures drug target levels and activity. For more information, please visit www.theralink.com.
About LD Micro
LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events on an annual basis, LD’s sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies.
http://www.ldmicro.com
Contact Information
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
valter@kcsa.com
Forward-Looking Statements
Certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, anything relating or referring to future financial results, patient enrollment and plans for future business development activities, and are thus prospective. Forward-looking statements are inherently subject to risks and uncertainties some of which cannot be predicted or quantified based on current expectations. Such risks and uncertainties include, without limitation, the risks and uncertainties set forth from time to time in reports filed by Theralink Technologies with the Securities and Exchange Commission. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends affecting the financial condition of our business and although the company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Consequently, future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements contained herein. The company undertakes no obligation to publicly release statements made to reflect events or circumstances after the date hereof.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/139977
Related Quotes
Don’t assume the worst is over, says investor Larry McDonald. McDonald, founder of The Bear Traps Report and author of “A Colossal Failure of Common Sense,” which described the 2008 failure of Lehman Brothers, expects more turmoil in the bond market, in part, because “there is $50 trillion more in world debt today than there was in 2018.” The bond market dwarfs the stock market — both have fallen this year, although the rise in interest rates has been worse for bond investors because of the inverse relationship between rates (yields) and bond prices.
You have just a few weeks to pounce on Treasury I bonds' sky-high interest rate. Also called Series I savings bonds, their interest rate is 9.62%.
Intel reports quarterly results on Oct. 27. Its last big layoff round, comprising 12,000 job cuts, was announced in tandem with first-quarter earnings in 2016.
After the annus horribilis of 2022, with the final quarter now in play, investors will be hoping a late-year rally will materialize. According to Carson Group's chief market strategist Ryan Detrick, that’s not such a far-fetched idea. "While October has a reputation for crashes, it is really a bear market killer,” Detrick recently wrote. “Of the past 17 bear (or near bear markets), stocks bottomed in October six times. Could it happen again? With sentiment this pessimistic and extremely positive
The stock market had a mixed performance on Tuesday, trading higher for parts of the day but finishing with new closing lows for the year for the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC). The Dow Jones Industrial Average (DJINDICES: ^DJI) managed to hold onto some modest gains, but they were quite a bit smaller than they'd been earlier in the afternoon. High-growth tech stocks once again found themselves in the crosshairs of bearish investors on Tuesday, extending losses from earlier in the year amid ongoing concerns about inflation.
Nio (NYSE: NIO) is working to expand beyond China, but right now investors are trading the company knowing its main market is still China. Last week, Nio outlined its strategy to continue its push into the European market.
It's common for companies to up their dividend payouts when business is fruitful, allowing investors to build up a cash pile quickly.
Tired of hearing about inflation? Well, tough luck. That is once again this week’s hot topic. On the agenda, the wholesale and consumer inflation reports – out Wednesday and Thursday, respectively. Considering the market’s latest pullback, Wall Street is evidently on edge following a good-is-bad jobs report, with little expectation the Fed will be relaxing its monetary policy anytime soon. Q3 earnings are also about to kick off and financial statements will offer a clue on inflation and rising c
One of the 800-pound gorillas in the auto industry will compete head-to-head with the company in an important segment.
Shares of electric-vehicle giant Tesla have gone through a brutal stretch lately. Bulls might be getting some relief soon.
It's looking like a rough day for stocks. Our call of the day is a look at the future and a billion-dollar industry and some stocks to play it, from Citigroup.
XPeng Inc. Sponsored ADR (XPEV) closed at $9.41 in the latest trading session, marking a -1.36% move from the prior day.
Shares of Credit Suisse are tumbling after reports surfaced that the Justice Department is investigating its role in asset hiding.
Nikola (NKLA) closed the most recent trading day at $2.99, moving -0.33% from the previous trading session.
Layoffs may be on the way at Intel, Oregon’s largest employer. The moves would come as the semiconductor industry is pushing the state for more incentives. Bloomberg, citing unnamed sources, reported late Tuesday that Intel is planning significant workforce reductions that could affect the sales and marketing division.
If you're searching for a low-risk, high-yield dividend stock, this wireless leader could be worth considering.
A Cowen analyst says chip stocks are near all-time low valuations after their big drops this year. Several offer solid buying opportunities.
The Nasdaq and S&P 500 sank to new bear market lows Tuesday as chip stocks and Tesla slumped. Big inflation reports are ahead.
U.S. national debt is above $31 trillion for the first time as the Federal Reserve is in retreat from buying it and foreign investors' interest is waning.
Shares of several mortgage real estate investment trusts (REITs) rose today after they provided preliminary results for the third quarter of the year. Shares of Annaly Capital Management (NYSE: NLY) rose 11.6%, while shares of AGNC Investment Corp (NASDAQ: AGNC) rose nearly 10.9%, and shares of Orchid Island Capital (NYSE: ORC) ended the day up nearly 13%. It also estimated that its tangible net book value per common share at the end of Q3 was roughly between $9.06 and $9.10 per share.